Professor Julie Frearson leads Charles River Discovery’s effort in developing new partnerships within all life sciences sectors in USA & Asia Pacific and is also driving our engagement with the marketplace via innovative business models. Julie has substantial experience in early stage drug discovery across multiple gene families and therapeutic areas as a result of roles in The Babraham Institute Cambridge UK, Zeneca UK, BioFocus and a faculty position at University of Dundee’s Drug Discovery Unit. As Professor of Molecular Pharmacology, Julie co-founded and raised >$30m to develop operations at Dundee directing translational drug discovery portfolios across a range of neglected diseases and for novel targets addressing oncology, rare genetic disease and stem cell fate. Julie is a strong advocate of early translational drug discovery from academic concepts and has served as SULSA Director of Translational Biology for Scotland and on MRC and Wellcome Trust Committees. Julie is co-author of more than 60 peer-reviewed publications.